11.2.3—Monoclonal antibody uses

A monoclonal antibody binds one target antigen with high specificity. That selective binding can reveal where the target is, or attach an intervention to cells or molecules carrying the target.

• Diagnostic detection: A monoclonal antibody can bind a pathogen antigen or a marker on a cancer cell. A visible or measurable label on the antibody then reveals whether the target is present; examples include tests for HIV, detection of bacterial pathogens, distinguishing related viruses, and locating blood clots by labelled antibody binding to fibrin.
• Targeted treatment: A monoclonal antibody can bind a chosen cell-surface protein or inflammatory target, so the associated immune or therapeutic effect is focused on cells or processes carrying that target. SME-supported examples include treatment directed at cancer cells, reducing an inflammatory response, and supplying purified antibodies against rabies virus.
• Other selective uses: The same binding principle supports research or separation work when a particular antigen must be captured or identified rather than all surrounding molecules.

Specificity is the control point: target antigen present → monoclonal antibody binds → the attached label makes the target detectable, or the attached/triggered action changes the target-bearing cell or process. The method is selective because unrelated antigens are not the intended binding target.

This card covers what monoclonal-antibody specificity enables. Antibody structure and general effector functions belong to 4633; hybridoma production belongs to 4634; immunity types and vaccination belong to the later objectives. A diagnostic signal shows target binding, not automatically the severity or complete cause of disease.